---
title: "\"Profit Warning\" STYLAND HOLD forecasts a mid-term loss narrowed to 9.58 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266074357.md"
description: "STYLAND HOLD issued a profit warning, expecting a loss of approximately HKD 9.58 million for the six months ending in September, compared to a loss of HKD 18.02 million in the same period last year. The reduction in loss is mainly due to increased revenue; an increase in the fair value changes of financial assets; and a decrease in financing costs, although partially offset by an increase in selling and distribution costs"
datetime: "2025-11-16T10:24:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266074357.md)
  - [en](https://longbridge.com/en/news/266074357.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266074357.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/266074357.md) | [繁體中文](https://longbridge.com/zh-HK/news/266074357.md)


# "Profit Warning" STYLAND HOLD forecasts a mid-term loss narrowed to 9.58 million yuan

STYLAND HOLD (00211.HK) issued a profit warning, expecting a loss of approximately HKD 9.58 million for the six months ending in September, compared to a loss of HKD 18.02 million in the same period last year. The reduction in loss is mainly due to increased revenue; an increase in the fair value changes of financial assets; and a decrease in financing costs, although this was partially offset by an increase in selling and distribution costs

### Related Stocks

- [STYLAND HOLD (00211.HK)](https://longbridge.com/en/quote/00211.HK.md)

## Related News & Research

- [Styland Subsidiary Commits US$3.4 Million to Alpha Perpetual Income Fund](https://longbridge.com/en/news/281380835.md)
- [A Look At Fosun International (SEHK:656) Valuation After Recent Mixed Share Price Performance](https://longbridge.com/en/news/281035263.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md)
- [Osl Group FY adjusted non-IFRS income HK$534.1 million](https://longbridge.com/en/news/281223382.md)
- [Butong Group Expands Share Pool for Award Scheme With On-Market Purchase](https://longbridge.com/en/news/280828310.md)